<DOC>
	<DOCNO>NCT01030952</DOCNO>
	<brief_summary>A 3-week , multi-center , open-label , randomize , active-control , parallel-group study compare effect Nateglinide Acarbose postprandial glucose fluctuation Chinese drug-naive patient type 2 diabetes mellitus ( T2DM ) . In study , participant different group take Nateglinide dose 120 mg orally three time daily 3 week Acarbose dose 50 mg three time daily 3 week , respectively .</brief_summary>
	<brief_title>Effects Nateglinide Postprandial Glucose Excursion Restoring Early Phase Insulin Secretion</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<mesh_term>Nateglinide</mesh_term>
	<criteria>Inclusion criterion 1 . Patients must give write informed consent assessment perform . 2 . Male , nonfertile female female childbearing potential use medically approve birth control method base local regulation . 3 . Drug naïve type 2 diabetes patient , define neither take consecutive antihyperglycemic drug treatment 3 month anytime , antihyperglycemic drug treatment 4 week prior visit 1 . 4 . Age range 1875 year inclusive . 5 . HbA1c range &gt; 6.5 ≤9.0 % Visit 1 . Exclusion criterion 1 . Pregnant nursing ( lactate ) woman , pregnancy define state female conception termination gestation , confirm positive hCG laboratory test ( &gt; 5 mIU/mL ) . 2 . With known hypersensitivity Nateglinide , Acarbose excipients . 3 . A history , 1. type 1 diabetes , diabetes result pancreatic injury , secondary form diabetes , e.g. , Cushing 's syndrome acromegaly . 2. acute metabolic diabetic complication ketoacidosis hyperosmolar state ( coma ) within past 6 month . 3 . Torsades de pointes , sustain clinically relevant ventricular tachycardia ventricular fibrillation . 4. percutaneous coronary intervention within past 3 month . 5. follow within past 6 month : myocardial infarction ( MI ) , coronary artery bypass surgery , unstable angina , stroke . 4 . Evidence significant diabetic complication , e.g. , symptomatic autonomic neuropathy gastroparesis . 5 . Acute infection may affect blood glucose control within 4 week prior visit 1 . 6 . Congestive heart failure require pharmacologic treatment . mg/dL ( 123μmol/L )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Diabetes Mellitus , Type 2</keyword>
	<keyword>Nateglinide</keyword>
	<keyword>Acarbose</keyword>
	<keyword>glucose fluctuation</keyword>
</DOC>